Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/155835
Full metadata record
DC FieldValueLanguage
dc.creatorAl-kuraishy, HM
dc.creatorAl-Gareeb, AI
dc.creatorAbdullah, SM
dc.creatorMartins, N
dc.creatorBatiha, GES
dc.date.accessioned2023-12-15T12:31:23Z-
dc.date.available2023-12-15T12:31:23Z-
dc.date.issued2021
dc.identifier.issn2297-055X
dc.identifier.urihttps://hdl.handle.net/10216/155835-
dc.description.abstractGilbert syndrome (GS) is a liver disorder characterized by non-hemolytic unconjugated hyperbilirubinemia. On the other hand, Coronavirus disease 2019 (Covid-19) is a recent viral infectious disease presented as clusters of pneumonia, triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). Little is known on the association between SARS-CoV-2 and GS, despite different studies have recently stated a link between hyperbilirubinemia and SARS-CoV-2 severity. In this case-report study we described a 47-year-old man, a known case of GS since the age of 4, presented to the emergency department with fever (39.8°C), dry cough, dyspnea, headache, myalgia, sweating and jaundice diagnosed with Covid-19-induced pneumonia. Interestingly, GS patient exhibited a rapid clinical recovery and short hospital stay compared to other SARS-CoV-2 positive patient, seeming that hyperbilirubinemia may exert a protective effect of against Covid-19 induced-cardiometabolic disturbances. Data obtained here underlines that the higher resistance against Covid-19 evidenced by the GS patient seems to be due to the antioxidant, anti-inflammatory, and antiviral effects of unconjugated bilirubin.
dc.description.sponsorshipTo all members in College of Medicine, Al-Mustansiyria University. NC-M acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017).
dc.language.isoeng
dc.publisherFrontiers Media
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FPSI-GER%2F28076%2F2017/PT
dc.relation.ispartofFrontiers in Cardiovascular Medicine, vol.8:642181
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectGilbert syndrome
dc.subjectHyperbilirubinemia
dc.subjectMetabolic disease
dc.subjectSARS-CoV-2
dc.titleCase Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3389/fcvm.2021.642181
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.642181/full
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3389-fcvm.2021.642181.pdf360.81 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons